Community Health Centers Of Southeastern Iowa, Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 1223 S Gear Ave Ste 108, West Burlington, IA 52655 Phone: 319-753-5177 |
Southeast Iowa Regional Medical Center, Inc. General Practice Medicare: Medicare Enrolled Practice Location: 1221 S Gear Ave, West Burlington, IA 52655 Phone: 319-768-3626 |
The Gastroenterology Clinic, Plc Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1223 S Gear Ave, Suite 201, West Burlington, IA 52655 Phone: 319-758-9075 Fax: 319-758-9079 |
Community Health Centers Of Southeastern Iowa Inc Internal Medicine Medicare: Medicare Enrolled Practice Location: 1706 West Agency Road, West Burlington, IA 52655 Phone: 319-768-5858 Fax: 319-752-4653 |
Burlington Area Family Practice Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 W Agency Rd, West Burlington, IA 52655 Phone: 319-754-4242 Fax: 319-754-4079 |
Burlington Internal Medicine Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 118 W Wheeler St, West Burlington, IA 52655 Phone: 319-754-7749 Fax: 319-754-7756 |
News Archive
The field of immunotherapy has revolutionized the way people with incurable cancers are treated, saving the lives of many people whose disease would have otherwise been seen as a death sentence. Despite its success in treating people with deadly forms of leukemia and lymphoma, there are still many people who do not benefit from the treatment or eventually experience a relapse of their cancer.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
A complex autoimmune disease, rheumatoid arthritis (RA) is characterized by chronic inflammation and progressive joint damage. This process begins with hyperplasia, or excessive increase in size and thickness, of synovial tissue. Along with provoking cartilage and bone destruction, this abnormal tissue growth is resistant to apoptosis, the natural cell death vital to the generation of healthy new cells.
A new report developed by the National Eczema Society, in collaboration with and with funding from LEO Pharma, launches today, with insights from over 1,000 people affected by the condition in the UK.
Kaiser Health News provides a fresh take on health policy developments with "Over The Top?" by Lee Judge.
› Verified 6 days ago